Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
3100 results found
2025 ∙ Scott, J. Abers, M. S. Marwah, H. K. McCann, N. C. Meyerowitz, E. A. Richterman, A. Fleming, D. F. Holmes, E. J. Moat, L. E. Redepenning, S. G. Smith, E. A. Stoddart, C. J. Sundaram, M. E. Ulrich, A. K. Alba, C. Anderson, C. J. Arpey, M. K. Borre, E. Ladines-Lim, J. Mehr, A. J. Rich, K. Watts, C. Basta, N. E. Jarolimova, J. Walensky, R. P. Dugdale, C. M.
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026
All age groups COVID-19 RSV (Respiratory syncytial virus) Influenza Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.
Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review
All age groups Pregnant women COVID-19 Safety
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Adusei-Mensah, F. Olubamwo, O. Olaleye, S. Akter, L. Balogun, O. S. Moshoeshoe, R. J. Awoniyi, L. Olawuni, A. Kauhanen, J.
Updating the impact of mRNA COVID-19 vaccine exposure during pregnancy on obstetric and neonatal outcomes
Pregnant women COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Adisu, M. A. Habtie, T. E. Kitaw, T. A. Zemariam, A. B.
Uptake of the Second Dose of the Measles Vaccine and Its Determinants Among Children Aged Less Than 5 Years: Systematic Review and Meta-Analysis
Africa Ethiopia Newborn Children Measles Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Chen, A. M. H. Draime, J. A. Engert, M. Pachucki, A. Zan, T. Craig, E. Gibson, N. Chukwuemeka, C. Tubb, S. M. Cole, J. W.
Utilization of Provider-Patient Communication Tools and Approaches to Facilitate Vaccine Confidence: A Systematic Review
All age groups Parents/caregivers Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Pan, H. Yu, Y. Li, X. Wang, M. Wen, C. Dai, Q. Huang, L.
Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants
All age groups Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Golla, E. B. Geremew, H. Abate, A. Ali, M. A. Simegn, M. B. Tilahun, W. M. Kuse, S. A. Wondie, S. G.
Vaccination dropout and associated factors among children in Ethiopia: a systematic review and meta-analysis (2014-2024)
Africa Ethiopia Newborn Children Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Virk, S. Milewski, A. Khan, N. Cheung, C. Wright, D. N. Kaur, G.
Vaccination in Forcibly Displaced, Pediatric Populations: A Systematic Review and Meta-Analysis
Newborn Children Adolescents Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ohnishi, T. Wakiguchi, H. Ishimori, S. Itoh, N. Yashiro, M. Yamazaki, S. Okafuji, I. Ohtomo, Y. Kobayashi, I.
Vaccination in paediatric, adolescent, and transitional-age rheumatic diseases: A systematic review
All age groups Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Gabor, M. Schlosserova, A. Korchynska, O. O.
Vaccination in pregnancy: a systematic review of current evidence
Pregnant women Influenza Pertussis COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...